News 28 Years Later: The Bone Temple 28 Years Later: The Bone Temple Trailer Has Ralph Fiennes Wielding a Potential Cure His test subject? None other than everyone’s favorite infected, Samson By Vanessa Armstrong | Published on December 3, 2025 Screenshot: Sony Pictures Comment 0 Share New Share Screenshot: Sony Pictures When the infected attack, what do they see? That’s a question Ralph Fiennes’ Dr. Kelson raises in the latest trailer for 28 Years Later: The Bone Temple, the sequel from director Nia DaCosta that follows up on the story Danny Boyle and Alex Garland established in the first film in their planned 28 Years Later trilogy. The trailer also reveals what Kelson is up to and what’s in store for Spike, something that the synopsis hints at as well: In a continuation of the epic story, Dr. Kelson (Fiennes) finds himself in a shocking new relationship—with consequences that could change the world as they know it—and Spike’s (Alfie Williams) encounter with Jimmy Crystal (Jack O’Connell) becomes a nightmare he can’t escape. In the world of The Bone Temple, the infected are no longer the greatest threat to survival—the inhumanity of the survivors can be stranger and more terrifying. Dr. Kelson’s shocking new relationship is with Samson, an infected who, as we see in this trailer, the good doctor thinks he can cure of the zombie-like disease. Will Dr. Kelson be successful? Will young Spike survive his time with the blond-haired Jimmy, who, as we also get hints at in this trailer, remains mentally unwell (as does Dr. Kelson, for that matter, with his titular Bone Temple, which he explains is a memorial for the dead)? Whatever else the film has in store for us, one thing is clear from this trailer: Dr. Kelson is taking a leap into the unknown with his potential cure. We’ll be able to go with him when 28 Years Later: The Bone Temple premieres in theaters on January 16, 2026. Check out the trailer below. [end-mark] The post <i>28 Years Later: The Bone Temple</i> Trailer Has Ralph Fiennes Wielding a Potential Cure appeared first on Reactor.